In 5-10% of CML patients, the 5'BCR/3'ABL1 fusion gene arises from complex variant rearrangements which may involve one or more chromosomes in addition to 9 and 22 [2,3]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.